Featured Application: 1. Fractures of the tibial plateau are common, representing 1% of all human fractures. Conservative and surgical treatments have been described for their management. 2. Comminuted or displaced fractures of the plateau can be challenging for orthopaedic surgeons, requiring often the use of bone grafts. 3. Autologous iliac bone graft (AIBG) is the clinical gold standard for bone transplantation. Still, this procedure exposes patients to some relevant risks. 4. Autologous iliac bone graft is the clinical gold standard for bone transplantation. Still, this procedure exposes patients to some relevant risks. 3. In order to overcome risks and limitation of AIBG, biomaterials are valuable bone substitutes when bone transplantation is required.
Secondary endpoint was to evaluate the ability of the xenograft to integrate with the surrounding bone tissue and promote new bone matrix deposition.
Materials and Methods

Clinical Data
The present study was reported according to the STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) guidelines (www.strobe-statement.org). All procedures were performed in strict accordance with the recommendations of the Declaration of Helsinki as revised in Fortaleza (2013) for investigations with human subjects and followed good clinical practice (GCP). The study protocol was approved by the United Ethical Committee of the "Città della Scienza e della Salute", Turin, Italy (approval n. 0004336), which comprehends also the hospital were all patients were treated. All patients signed an informed consent form to document that they understood the aims of the study and authorized the use of their data for research purposes. Patients were allowed to ask questions pertaining to this study and were thoroughly informed consequently.
Study Design, Patients' Selection, and Endpoints
We performed a retrospective analysis of our prospectively collected database of patients treated for tibial plateau fracture, in order to assess the mid-term safety and biomechanical performances of SB, which we used as bone substitute for the surgical treatment of our patients.
The study is based on clinical data and radiological images prospectively harvested before, during, and after the procedure. We considered patients treated for tibial plateau fracture at our institution from May 2017 to January 2018. None of the patients included in the study suffered major soft tissue damages other than local haematoma. Inclusion criteria to participate this study were: age > 18; patients who expressed their informed consent to participate the study; diagnosis of tibial plateau fracture; bone augmentation with SB; availability of complete clinical and radiological data from follow-up. Exclusion criteria were: age < 18 and the presence of comorbidities, like metabolic bone diseases (such as e.g. hyperparathyroidism and dialysis), diabetes, or malignancies. Differences in gender or tobacco use were not exclusion criteria. Primary osteoporosis was not considered in the patient selection.
Surgical Technique and Rehabilitation
All patients had surgery within 48 hours from injury, after administration of spinal or general anaesthesia. A tourniquet was routinely positioned before starting surgical procedure; all patients were operated in a supine position, with injured leg in semi-flexion. Fractures were reduced through a percutaneous or open approach, depending on the cases; SB blocks, which size and shape were customised during surgery considering the features of bone defect for each singular patient, were positioned through a minimally invasive approach via the bony window exploited for reduction; finally, fixation of fracture line and implant were performed with screws and plates (see exemplificative . In one case fixation of the plateau fracture occurred through an arthroscopic approach. All the patients included in the study had identical post-operative regimen. Active knee mobilization and static quadriceps exercises were encouraged from the third day after surgery. Partial weight bearing was allowed at 4-6 weeks after surgery, and progressively increased to achieve full weight bearing at 12 weeks. Prophylaxis for thromboembolic events was obtained through administration of 4000 IU/day of low molecular weight heparin (LMWH) (enoxaparin), until full weight bearing was allowed.
Statistical Analisis
Categorical variables are expressed as frequencies (percentages); continuous variables are expressed as mean ± standard deviation (SD). Student t-test was used to compare independent means. Significance was set at p < 0.05. 
Categorical variables are expressed as frequencies (percentages); continuous variables are expressed as mean ± standard deviation (SD). Student t-test was used to compare independent means. Significance was set at p < 0.05.
Follow-Up.
Patients were clinically and radiologically assessed before surgery, at 2 weeks, and then at 1, 2, and 6 months, and 1 year after surgery. Same radiologist carried out the imaging, while evaluations were pooled by different clinicians. Clinical assessment consisted of a visual analogue scale (VAS) for the evaluation of pain, where patients were asked to report the level of pain during the day life activities; measurement of the range of motion (ROM) of the knee joint; and objective examination, intended to highlight possible alterations of surgical scar, vascular and nervous deficits, as well as infectious complications. Moreover, at 1-year follow-up Tegner Lysholm Knee Scoring Scale [21] and International Knee Document Committee 2000 (IKDC 2000) [22] questionnaires were administered during control visits, in order to evaluate patients' subjective perception of knee function. One year after surgery, patients answered to the Short Form (36) Health Survey (SF-36) questionnaire, which scores the general physical and mental health on the basis of eight scales each ranging from 0 to 100 
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Follow-Up
Patients were clinically and radiologically assessed before surgery, at 2 weeks, and then at 1, 2, and 6 months, and 1 year after surgery. Same radiologist carried out the imaging, while evaluations were pooled by different clinicians. Clinical assessment consisted of a visual analogue scale (VAS) for the evaluation of pain, where patients were asked to report the level of pain during the day life activities; measurement of the range of motion (ROM) of the knee joint; and objective examination, intended to highlight possible alterations of surgical scar, vascular and nervous deficits, as well as infectious complications. Moreover, at 1-year follow-up Tegner Lysholm Knee Scoring Scale [21] and International Knee Document Committee 2000 (IKDC 2000) [22] questionnaires were administered during control visits, in order to evaluate patients' subjective perception of knee function. One year after surgery, patients answered to the Short Form (36) Health Survey (SF-36) questionnaire, which scores the general physical and mental health on the basis of eight scales each ranging from 0 to 100 [23] . Radiological assessment contemplated the acquisition of anteroposterior and lateral projections radiographs at each follow-up. Images were examined in order to evaluate various features of healing process, like callus formation and maintenance of fracture reduction; as well as to detect the presence of possible malalignment, pseudo-arthrosis, bone non-unions, and articular surface depression or widening (see exemplificative Figures 1-3) .
Patients, where timing allowed, where further controlled at 2 years with general clinical follow-up.
Results
Demographics and Type of Fracture
Thirty-four patients met the inclusion criteria and were included in the study: 18 males (53%) and 16 females (47%). Average age of this group of patients was 57.5 (std. 12.72) years, ranging from 32 to 81 years. Schatzker type II fractures were identified in 18 patients (52.9%), Schatzker type III in 6 patients (17.6%), and Schatzker type VI in 10 patients (29.4%). Right lower limb was involved in 21 cases; in the remaining 13 cases left side was affected. Weight, height, and Body Mass Index (BMI) of each patient were also recorded and are synthesised in Table 1 . 
Clinical Assessment
The average values recorded from VAS for pain evaluation decreased from 6.33 ± 1.40 points at the first 2 weeks follow-up, to 1 ± 0.79 at 1 year (P < 0.0001). Detailed data about average values from VAS in Table 2 . At 1-year post-surgery mean ROM was 124 ± 6 • . Overall, all patients showed a symmetrical performances recovery. None of the 34 patients who participated the study reported vascular or nervous deficits. Moreover, we did not observe any clinically evident infectious complication.
At 1 year, the average score obtained from Tegner Lysholm Knee Scoring Scale was 89 ± 4.10; the average score derived from IKDC 2000 questionnaire was 78.67 ± 3.31.
The average values of each scale of the SF-36 are reported in Table 2 .
Radiological Assessment
At each follow-up, we did not observe neither fracture recurrences nor radiographically noticeable subsidence or diastasis of the articular surface at follow up.
We did not detect pseudo-arthrosis, nor bone non-unions nor delayed consolidations [24] . Articular alignment was considered acceptable in all 34 cases at each evaluation (see also Figure 4 ).
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We did not detect pseudo-arthrosis, nor bone non-unions nor delayed consolidations [24] . Articular alignment was considered acceptable in all 34 cases at each evaluation (see also Figure 4 ). At six months, X-rays images showed that all 34 fractures displayed a good consolidation rate, as confirmed by radiological reports. In particular, radiolucency of the xenografts was assessed [20] , which became progressively more similar to that of the surrounding healthy bone tissue (see exemplificative Figures 1-3 and comparative images in Figure 4 ).
Statistical Analysis
The results are reported in Table 1 and 2.
Long-term Follow-up
All 34 patients where fully examined at 1-year follow-up, while, due to timing reasons, 26 patients (76.5%) were also clinically examined at 2 years follow-up, and 5 patients (14.7%) at 1.5 years. Only 3 patients had only a 1-year follow-up. All these 31 patients presented clinically stable conditions and stable performances of the affected limb. Hence, none of the patients observed either at 2 years and 1.5 years follow-up required any further imaging investigations. None of the patients treated with this technique has been lost at this follow up. At six months, X-rays images showed that all 34 fractures displayed a good consolidation rate, as confirmed by radiological reports. In particular, radiolucency of the xenografts was assessed [20] , which became progressively more similar to that of the surrounding healthy bone tissue (see exemplificative Figures 1-3 and comparative images in Figure 4 ).
Discussion
Statistical Analysis
The results are reported in Tables 1 and 2 .
Long-Term Follow-Up
All 34 patients where fully examined at 1-year follow-up, while, due to timing reasons, 26 patients (76.5%) were also clinically examined at 2 years follow-up, and 5 patients (14.7%) at 1.5 years. Only 3 patients had only a 1-year follow-up. All these 31 patients presented clinically stable conditions and stable performances of the affected limb. Hence, none of the patients observed either at 2 years and 1.5 years follow-up required any further imaging investigations. None of the patients treated with this technique has been lost at this follow up.
Discussion
Various strategies for the treatment of tibial plateau fractures have been described in the medical literature, so far. Conservative treatment, such as traction and cast bracing, are viable approaches only in selected cases [25, 26] . However, in general, conservative treatment displays poorer outcomes in comparison to surgery, due to the prolonged immobilisation in a cast brace or hospitalization required, which can eventually lead to joint stiffness, and further risks like pulmonary embolism and ulcers [3, 27] .
Allowing a more rapid return to mobilisation and weight bearing, surgery is preferable in most cases and closed reduction and minimally invasive fixation, ORIF, and arthroplasty are all valid techniques for the treatment of tibial plateau fractures [28] [29] [30] . Moreover, in some circumstances like challenging comminuted, displaced fractures, excessive loss of bone matrix or severe depressions of articular surface, bone graft substitutes to augment metaphyseal defects are needed. Historically, cancellous bone harvested from iliac crest has been considered the gold standard for bone grafting. A comprehensive review of the literature published in 2013 by Goff et al. [31] showed that AIBG was the most commonly performed procedure for bone augmentation in the management of tibial plateau fracture. However, this approach involves an additional incision to harvest the graft, which may eventually lead to infection, haematoma, neurovascular complications and fractures, overall representing a further risk exposure for the patients [9, 10, 31] . Furthermore, some variables like quantitative limitations to the bone that can be safely harvested, biological quality and structural strength of the graft are still concerning factors which led to the development of bone substitutes [16] . A vast variety of bone substitutes are available on market and currently used in clinical settings, each displaying some limitations [6, 32] . Recently, some authors have focused on investigating xenohybrid materials, which combine biological qualities of auto-and allo-grafts along with mechanical performances of synthetic scaffolds. The CXS we studied as bone graft in the treatment of tibial plateau fractures is a bovine bone-derived matrix enriched in poly(L-lactide-co-ε-caprolactone) (PLCL), in order to improve compressive strength and elasticity, and collagen fragments exposing the RGD sequence, which improve hydrophilicity, so favouring blood affinity, and enhance cells attachment [18] [19] [20] . It has been proved that its particular affinity to blood facilitates attachment by MSCs, which then differentiate in osteoblasts, leading to deposition of new bone matrix that eventually degrades and substitutes the CXS [7, 18] .
This CXS has already been safely used in oral and maxillary surgery with promising results, and its biological and mechanical characteristics make it an interesting tool for orthopaedic surgery as well [18, 33] .
Tegner Lysholm Knee Scoring Scale is a scoring system based on ten questions regarding function, pain and stability of the knee joint [20] . Scores <65 are considered poor; fair if comprised between 65 and 83; good when ranging from 84 to 90; excellent if >90 [34] . The mean Tegner Lysholm Knee Scoring Scale we obtained from our patients was 89 ± 4.10, which is considered good. IKDC 2000 is a form composed of ten sections, each one containing several questions, in which patient is questioned about subjective perception of knee function [35] . The final score is expressed in a scale from 0 to 100; mean IKDC 2000 of our patients was 78.67 ± 3.31, which indicates that 1 year after surgery patients were satisfied about the grade of their knee function. SF-36 is a questionnaire that assesses general health status through 36 questions [23] . The results of the questions are then transformed in eight scales, each one ranging from 0 to 100. The higher the score the higher the level of healthiness related to the parameter assessed by that specific scale. The mean values of SF-36 are reported in Table 2 . For each scale values are excellent and similar to those of the general population. Mean VAS decreased from 6.33 ± 1.40 to 1 ± 0.79, difference that we considered significant (p < 0.0001). None of the 34 patients reported any local complication related to the implant, nor neurovascular or infectious adverse effect, which points out the safety of the graft. We used literature data within our study as a referenced historical control group.
The comprehensive review of the literature published in 2013 by Goff et al. [31] analysed data from 672 patients from different studies, with different biomaterials used: fracture healing was uneventful in over 90% of the cases over a variant period of time; secondary collapse of the knee joint surface was reported in 8.6% in the biological substitutes, 5.4% in the hydroxyapatite, 3.7% in the calcium phosphate cement, and 11.1% in the calcium sulphate cases. The recorded incidence of primary surgical site and donor site infection (3.6%) was not statistically significant different, however donor site-related pain was reported up to 12 months following autologous iliac bone graft (AIBG) harvest, i.e. in the most commonly performed procedure for bone augmentation in the management of tibial plateau fracture. Bucholz et al. [36] reported good clinical outcomes in a series of patient with tibial plateau fractures treated with a hydroxyapatite bone substitute, however highlighting some complications like infections and collapses. Moreover, they considered the biodegradation process of the graft as slow. Keating et al. [37] described a series of 49 patients whom bone augmentation was performed with a CaP bone cement, reporting good results with regard to return to activity and clinical outcomes; however, 7% of patients presented complications. Similar results have been obtained by other authors, using the same type of synthetic biomaterial [38] [39] [40] . Moreover, Simpson et al. [38] reported a significant reduction in mean duration of surgery in patients treated with the CaP bone cement if compared with patients who underwent AIBG (55 vs 101 min, p < 0.0001), which have implications on overall costs of procedures [41] . We quantitatively assessed the grade of knee joint mobilisation, which is crucial to restore weight bearing, through measurement of the ROM. Our series of patients had a mean ROM of 124 ± 6 • at 1-year follow-up. Russel et al. [42] in a prospective, randomised, multi-centric study comparing CaP cement with AIBG, registered that 69% of patients of the study group had ROM > 120 • at average 12 months follow-up. Newmann et al. [43] studied a group of patients treated with allograft, that reported mean ROM of 118 • at 12 months; however, one patient presented osteomyelitis and in four cases subsidence of the joint.
Comparison with the current literature is challenging, due to the lack of standardised follow-up protocols and differences in quantitative assessment of outcomes among the studies. However, the implant of SB in our series resulted in a standard return to knee mobilisation, as highlighted by the mean ROM at last follow-up and the return to partial weight bearing at 4-6 weeks. We also described no complications, like infections and joint subsidence, if compared to similar studies present in the medical literature [31] . Radiological follow-up did not show diastasis or depressions of tibial articular surface excluding the incomplete subchondral reductions documented at the first post op X-ray, which means that mechanical properties of SB were adequate for high and complex forces which the plateau commonly undergoes. At each follow-up, the radiolucency of implants was progressively more similar to radiolucency of the surrounding bone (see exemplificative Figures 1 and 2) . We interpreted this evidence as supporting the thesis that SB would have been able to integrate with autologous bone tissue, favouring deposition of new bone matrix within an ongoing remodelling process: indeed, there is a clear morphological pattern on the evolution of the standard X-Ray imaging series over time which shows the substitution of the grafted material with a more homogeneous signal in the area of graft implant. As already demonstrated, the progressive remodelling together with an increase of the mineral signal cannot be dependent on the active remodelling of the graft per se given it is a decellularized matrix. Therefore, the increase in the density over time depends on novel mineral matrix apposition likely induced by the graft, as previously shown both in vivo and in vitro [7, 20] .
The literature on the use of xenografts in the setting of tibial plateau fractures is still limited. In 2009, Basel et al. [27] described clinical and radiological findings of a series of patient treated for tibial plateau fractures with bone xenograft, but their study did not include any quantitative assessment of outcomes. The majority of studies reported in the literature, about bone augmentation for the treatment of such fractures, involve AIBG; controlled studies comparing different types of bone graft are scarce [31] . However, innovative biomaterials for bone transplantation have demonstrated to be safe, reliable, and biocompatible tools for bone transplantation [16] . Their use resulted in most cases in reduced rate of complications, operative times, operative costs, and hospital length of stay, along with comparable or better results in term of clinical and radiological outcomes [8, [38] [39] [40] [41] . Furthermore, xenohybrid materials demonstrated that can be successfully used as carriers to locally administer drugs or MSCs, making them a useful resource for orthopaedic surgeons, in a variety of conditions [7, 20, 44, 45] . Hence, more clinical studies to better understand the role of biomaterials in orthopaedic surgery are encouraged. This study shows some limitations, like the relatively small number of patients having been chosen within the framework of an observational study, the retrospective nature of the analysis, which includes different subtypes of fractures and the lack of a pre-existing quantitative scale defining radiological outcomes; at this last regard, we had hence to develop a new protocol [20] . Also, the ROM of the contralateral (healthy) joint was not reported as it was considered as physiological, while the aim was to test the improvement in the operated joint. Finally, it would have been useful to evaluate a control group a that has been treated in the same hospital with the same clinical procedures in order to evaluate the influence of the bone substitute on the healing. Nevertheless, here we have collected strong clinical evidences already from the 1-year follow-up, being confirmed by all follow-ups (91.2%) recorded after 1.5 and 2 years, including the lack of long-term complications. Overall, collected data offers a confirmation to investigated clinical endpoints and confirms material properties too. A further study will address bone density and graft density on a selected group of patients using a novel TC protocol.
Conclusions
Clinical and radiological outcomes of our series of 34 patients treated for fractures of the tibial plateau were good and comparable to literature data [45] . At 1-year follow-up, the xenohybrid biomaterial we studied has demonstrated to be a safe bone substitute and to possess adequate mechanical and biological properties to sustain healing and consolidation of tibial plateau fractures. SB has also showed good biocompatibility and capacity of osteointegration. This evidence makes SB a valuable biomaterial for orthopaedic surgery when bone graft is required. Clinical Data: This study protocol was approved by the United Ethical Committee of the "Città della Scienza e della Salute", Turin, Italy (approval n. 0004336), which comprehends also the hospital were all patients were treated. All patients signed an informed consent form to document that they understood the aims of the study and authorized the use of their data for research purposes. Patients were allowed to ask questions pertaining to this study and were thoroughly informed consequently. All procedures were performed in strict accordance with the recommendations of the Declaration of Helsinki as revised in Fortaleza (2013) for investigations with human subjects and followed good clinical practice and ISO14155 prescriptions. The study is sponsored by Industrie Biomediche Insubri SA (Switzerland), coordinated by Dr. A. Bistolfi, co-author in this work, and monitored by Prof. Dr. G. Perale, co-author in this work.
